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Humoral immune response to avian influenza vaccination over a
six-month period in different species of captive wild birds
Abstract
In December 2005, the four major Swiss zoos carried out the vaccination of selected zoo birds with the
adjuvant inactivated vaccine H5N2 Nobilis influenza. Pre- and post-vaccination antibody titers were
determined either by hemagglutination inhibition (HI) test (non-Galliformes) or by enzyme linked
immunosorbent assay (ELISA) (Galliformes) at Week 0, 5, 10, and 26 (Day 0-1, 35-36, 70-71, and 182
respectively) to determine the humoral immune response to H5 antigen. After the first vaccination, the
overall geometric mean titer of non-Galliformes was 65 (n 5 142), which increased to 187 (n 5 139)
after booster vaccination and dropped to 74 (n 5 65) six months after first vaccination. For the
Galliformes group, the mean titers were found to be 2.09 at Week 5 (n 5 119), 3.24 at Week 10 (n 5
113), and 1.20 at Week 26 (n 5 39). Within the non-Galliformes, significant differences in geometric
mean titers were found among different species representatives. In general, the flamingos
(Phoenicopteriformes) showed a strong response to vaccination, reaching a geometric mean titer of 659
at Week 10, while the Sphenisciformes did not show high antibody titers even after booster vaccination,
reaching a maximum geometric mean titer of only 65. Based on the antibody titer profiles of all
investigated species, we recommend at least annual revaccination for the species  that we investigated.
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SUMMARY. In December 2005, the four major Swiss zoos carried out the vaccination of selected zoo birds with the adjuvant
inactivated vaccine H5N2 Nobilis influenza. Pre- and post-vaccination antibody titers were determined either by hemagglutination
inhibition (HI) test (non-Galliformes) or by enzyme linked immunosorbent assay (ELISA) (Galliformes) at Week 0, 5, 10, and 26
(Day 0–1, 35–36, 70–71, and 182 respectively) to determine the humoral immune response to H5 antigen. After the first
vaccination, the overall geometric mean titer of non-Galliformes was 65 (n 5 142), which increased to 187 (n 5 139) after booster
vaccination and dropped to 74 (n5 65) six months after first vaccination. For the Galliformes group, the mean titers were found to
be 2.09 at Week 5 (n5 119), 3.24 at Week 10 (n5 113), and 1.20 at Week 26 (n5 39). Within the non-Galliformes, significant
differences in geometric mean titers were found among different species representatives. In general, the flamingos
(Phoenicopteriformes) showed a strong response to vaccination, reaching a geometric mean titer of 659 at Week 10, while the
Sphenisciformes did not show high antibody titers even after booster vaccination, reaching a maximum geometric mean titer of
only 65. Based on the antibody titer profiles of all investigated species, we recommend at least annual revaccination for the species
that we investigated.
RESUMEN. Respuesta inmune humoral a la vacunacio´n contra influenza aviar durante un periodo de seis meses en diferentes
especies de aves silvestres en cautiverio.
En Diciembre del an˜o 2005, los cuatro zoolo´gicos ma´s grandes de Suecia implementaron la vacunacio´n con la vacuna inactivada
con adyuvante de influenza Nobilis H5N2 de aves seleccionadas de los zoolo´gicos. Para determinar la respuesta inmune humoral
contra el antı´geno H5, se determinaron los tı´tulos de anticuerpos mediante la prueba de inhibicio´n de la hemoaglutinacio´n (aves no
galliformes) o mediante la prueba de inmunoensayo asociado a enzimas (galliformes). Los ana´lisis se realizaron antes y despue´s de la
vacunacio´n a las 0, 5, 10, y 26 semanas (dı´as 0–1, 35–36, 70–71 y 182, respectivamente). Luego de la primera vacunacio´n, el
promedio geome´trico general del tı´tulo de las aves no galliformes fue 65 (n 5 142), que se incremento´ a 187 (n 5 139) luego de la
revacunacio´n para luego disminuir a 74 (n 5 65) seis meses posteriores a la primera vacunacio´n. Para el grupo de los galliformes, el
promedio de los tı´tulos fue de 2.09 en la semana cinco (n 5 119), 3.24 en la semana 10 (n 5 113) y 1.20 en la semana 26 (n 5
39). Dentro de las aves no galliformes, se observaron diferencias significativas en los promedios geome´tricos de los tı´tulos entre las
diferentes especies representadas. En general, los flamingos (Phoenicopteriformes) mostraron una respuesta fuerte a la vacunacio´n,
alcanzando tı´tulos con promedios geome´tricos de 659 a la semana 10, mientras los Sphenisciformes (pingu¨inos) no mostraron tı´tulos
altos de anticuerpos incluso despue´s de la revacunacio´n, alcanzando un tı´tulo ma´ximo de solo 65. Basados en los perfiles de
anticuerpos de todas las especies investigadas, se recomienda la revacunacio´n al menos anual de estas especies.
Key words: antibody titer, avian influenza, serology, vaccination, zoo
Abbreviations: AI5 avian influenza; CI5 confidence intervals; ELISA5 enzyme linked immunosorbent assay; GMT5 geo-
metric mean titer; HA5 hemagglutinin; HAU5 hemagglutinating units; HI5 hemagglutination inhibition; HPAI5 highly
pathogenic avian influenza; IM5 intramuscular; NA5 neuraminidase; S/P5 sample to positive ratio
Influenza viruses are pleomorphic, enveloped, single-stranded
RNA viruses of the family Orthomyxoviridae. They are classified as
types A, B, and C, based on the antigenic differences between their
nucleoproteins and matrixproteins (4). The influenza B and C
viruses are not divided into subtypes, in contrast to influenza A
viruses, which are further classified based on the divergence between
their two major antigenic determinants, hemagglutinin (HA) and
neuraminidase (NA) (12,19). To date, 16 HA and 9 NA subtypes of
influenza A viruses have been identified (8). Viruses are additionally
characterized by their hosts, geographic origin (place of isolation),
strain number, year of isolation, and finally the subtype; all enclosed
in parentheses (4,10). Influenza A viruses are found in a large variety
of mammals and birds (8). Aquatic birds such as Anseriformes
(waterfowl) and Charadriiformes (shorebirds) represent the natural
reservoir of the influenza A viruses (17) and have been demonstrated
to be susceptible for all of the 16 HA and 9 NA subtypes (12,13).
Influenza viruses of the HA subtype H5 and H7 are the etiologic
agents of a highly contagious, and frequently serious, acute
respiratory and gastrointestinal disease in aviculture, causing
considerable financial losses in affected areas as well as in
neighboring regions (7).
Highly pathogenic and notifiable low-pathogenic avian influenza
viruses pose a special peril to zoos, considering that the birds they
keep are often of great value from the point of view of conservation.
The disease poses a twofold threat, by either 1) the epidemic itself, or
by 2) the control measures adopted when a notifiable avian influenza
virus is identified in the population, measures which often include
culling- or stamping-out of birds within the affected areas. Because
treatment of avian influenza in birds is not considered an option,
prevention of the disease by vaccination has been recommended
(2,21).
Commercial vaccines are available for poultry (6), and it has been
shown that such vaccines also protect ducks. It was demonstrated
that vaccinated birds do not develop clinical signs when infectedCCorresponding author. E-mail: Jean-Michel.Hatt@access.uzh.ch
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with the challenge viruses, and that vaccinated ducks had reduced
shedding of the challenge virus (3,20,22). Vaccination has also been
discussed as an option to protect rare species in zoological gardens
(5). Vaccination studies of multispecies bird collections in zoos have
been carried out with H7N2 and H5N2 vaccines in Dutch zoos
(16,17), with H5N2 vaccine at the Singapore zoo (14), and with
H5N9 vaccine in Danish zoos (1). From these reports, it could be
concluded that vaccination is safe, and that the vaccine elicits a
humoral immune response. However, there are also reports in these
studies describing differences in antibody mediated immune
responses among avian species. Furthermore, antibody titer profiles
over an extended period of several months were not investigated in
nondomestic birds. In Galliformes, annual boostering is recom-
mended (5), but the interval for other species is not known.
Therefore, the purposes of this study were to examine the species-
dependent humoral immune responses among zoological avian
collections following vaccination with a commercial H5N2 avian
influenza vaccine, and to determine the decrease of antibody titers,
after a period of six months, in regard to the estimation of the likely
interval of revaccination in different species.
MATERIALS AND METHODS
Animals. In the present study, 365 birds were vaccinated in the four
Swiss zoos of Basel, Berne, Goldau, and Zurich (Table 1). The selection
of animals reflects aspects such as susceptibility to avian influenza,
conservation status, housing conditions, and size of population. All
animals involved in the study were clinically healthy. All birds were
continuously monitored by the attending veterinarian and by the keepers
for adverse reaction to vaccination. Experimental procedures were
evaluated and approved by the cantonal Animal Care and Use
Committee and licensed under number 192/2005.
Vaccination. Birds were vaccinated twice, with an interval of five
weeks (on Day 0–1 and Day 35–36), with an inactivated H5N2 vaccine,
(strain A/Chicken/Mexico/232/95/CPA [H5N2]) with liquid paraffin
adjuvant (Intervet, Boxmeer, Netherlands). This vaccine strain was
chosen in regard to the avian influenza virus strain circulating across
Europe in 2005 and with respect to ‘‘differentiating infected from
vaccinated animals’’—the DIVA concept.
Doses were 0.25 ml for bird species with a body weight below 1.5 kg;
0.5 ml for species with a body weight between 1.5 kg and 20 kg; and
1.0 ml for species with a body weight$ 20 kg. The vaccine was injected
subcutaneously in the dorsal cervical region or in the femoral region, and
intramuscularly in the pectoral or the femoral region. Pelicans (Pelecanus
crispius) were injected intramuscularly in the femoral region due to the
large extension of their subcutaneous air sacs (18). Other species, such as
Recurvirostra avosetta (pied avocet) and Athene noctua (little owl), were
injected intramuscularly due to their small size.
Blood collection protocols. Blood sampling was performed on the
day of first vaccination (Day 0–1) and at Week 5 (Day 35–36; booster
vaccination), Week 10 (Day 70–71), and Week 26 (Day 182). Sampling
sites were the vena brachialis, v. metatarsalis medialis, or the v. jugularis
dextra, and a minimum of 1 ml blood was collected from each sampled
bird. The blood was collected in Eppendorf (microfuge) tubes (2.5 ml),
separated at 2400 3 g for 5–10 minutes, 1–8 hours after collection, and
serum was stored at 220 C until analysis.
Inhibition of hemagglutination. All non-Galliformes sera were
analyzed for the presence of anti-H5 antibodies using the HI test
following standard procedures (11), and using chicken red blood cells
(15). Back titration of antigen (Antigen lot. no. 822, strain A/chicken/
Mexico/232/95/CPA [H5N2]), (Intervet) was included in all tests to
quantify the number of HAUs contained in 25 ml antigen.
Hemagglutination inhibition titers were regarded as positive at a
serum dilution of 1:16 (in other words, a geometric mean titer (GMT)
$ 16 represents positive titers) or more against 4 HAU of antigen (15).
Geometric mean titer and confidence intervals (CI) of 95% were
subsequently calculated per avian order (Anseriformes, Ciconiiformes,
Coraciiformes, Falconiformes, Passeriformes, Pelicaniformes, Phoeni-
copteriformes, Psittaciformes, Sphenisciformes, and Strigiformes), with
the exception of orders with a small number of individuals (,10).
ELISA. All sera from Galliformes collected during the 26-week
period were analyzed by the IDEXX FlockChek AI ELISA (IDEXX
GmbH, Ludwigsburg, Germany), an assay designed to measure the
relative level of antibody to AI in chicken and turkey serum. The main
reasons for utilizing the IDEXX ELISA to test Galliformes were that this
test is 1) rapid and reliable; 2) a good option to the HI test for
Galliformes; and 3) sensitive not only to H5 but also to antibodies
against 13 other HAs. This analysis was performed according to the
manufacturer’s instructions. The positive control was standardized and
represented significant antibody levels to AI in chicken serum. The
relative level of antibody in the unknown was determined by calculating
the ratio of the sample (S) to the positive (P) control (S/P). All S/P ratios
$ 0.5 were considered positive. Mean titers and CI of 95% were
subsequently calculated per species (rock partridge, Australian brush-
turkey, brahma chicken, barth chicken, cochin chicken, orpington
chicken, silky chicken, Himalayan monal, turkey, common peafowl,
capercaille, and satyr tragopan), with the exception of species with small
number of individuals (n , 10).
Correlation between HI test and ELISA. Evaluations and the
comparison of the common HI and the IDEXX FlockChek AI ELISA
test were performed by IDEXX Laboratories as well as by laboratories in
Mexico and China. These examinations revealed a high correlation
(between 96.3% and 100%) between the two tests (9).
Statistical methods. Pre-vaccination and post-vaccination antibody
titers were subjected to statistical analysis to evaluate significance in
differences observed among and within orders, species, and sampling
dates. The Friedman ANOVA and Kendall coefficient of concordance
were used to assess whether samples from at least one sampling date
would differ from the other three. To allow individual comparison
regarding observed differences in antibody titer, both within the orders
and at different points in time, the Wilcoxon matched pairs test was
performed. To assess whether there would be significant differences
among orders within the same sampling week, antibody titers were
analyzed, by ranks, with a Kruskal-Wallis ANOVA and by Mann-
Whitney U-test; values of P , 0.05 were considered significant.
RESULTS
A total of 365 birds, belonging to 14 orders and representing 56
species, were vaccinated (Table 1). The vaccine was well tolerated by
all birds, and no clinically significant reaction was noted at the
injection site. In one peacock (Pavus cristatus), euthanatized ten
weeks after first vaccination for reasons unrelated to the study, a
2 cm 3 1.5 cm subcutaneous inflammation at the injection site was
noted. Three casualties occurred, one of which was a common
kestrel (Falco tinnunculus) that escaped. Two birds died during the
sampling procedure; a cattle egret (Ardeola ibis) due to hemorrhages
and a satyr tragopan (Tragopan satyra) due to stress. During the 26–
week study period, a total of 872 samples were taken from these
birds.
For the serological survey, 256, 261, 252, and 103 samples were
taken at first (Week 0 or Day 0–1) and second (Week 5 or Day 35–
36) vaccination and at Week 10 (Day 70–71) and 26 (Day 182).
The last sampling period took place in June, when many of the birds
involved in the study were brooding. To avoid the risk of incubation
damage, the zoos decided to spare the birds additional stress,
resulting in a significant drop in the number of study birds.
Statistical analysis of pre-vaccination and post-vaccination
antibody titers revealed significant differences among and within
orders. Table 2 summarizes the serum antibody titers of the different
non-Galliformes orders. In total, 484 sera from 169 vaccinated non-
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Table 1. Number, species, and GMT or S/P ratio of birds vaccinated with an inactivated H5N2 vaccine at Weeks 0, 5, 10, and 26.A
Order No. vacc.
No. tested GMT or S/P ratio
Species
common name
Species
scientific nameWk 0 Wk 5 Wk 10 Wk 26 Wk 0 Wk 5 Wk 10 Wk 26
Total no. of birds 365 256 261 252 103
Anseriformes 51 40 37 36 30 1 78.4 266.6 113
6 6 4 4 4 1 53.8 80.6 40.3 domestic duck Anas platyrhynchos f.
domesticus
1 (–) (–) (–) (–) (–) (–) (–) (–) green-winged teal Anas crecca crecca
1 1 1 1 1 1 32 128 aa Meller’s duck Anas melleri
3 3 2 2 1 1 128 128 32 bronze-winged duck Anas specularis
2 2 2 2 1 2 32 45.3 32 Diepholzer goose Anser anser diepholzer
4 4 4 3 3 1 22.6 80.6 45.3 greylag goose Anser anser
7 7 7 7 7 3 128 1024 420 bar-headed goose Anser indicus
2 2 2 2 1 1 45.3 181 32 Egyptian goose Alopochen aegyptiacus
5 (–) (–) (–) (–) (–) (–) (–) (–) ferruginous duck Aythya nyroca
4 4 4 4 3 1 16 430.5 161 Hawaiian goose Branta sandvicensis
2 2 2 2 2 1 90.5 365 128 Cape Barren goose Cereopsis
novaehollandiae
3 3 3 3 3 1 64 512 161 Magellan goose Chloephaga picta
2 (–) (–) (–) (–) (–) (–) (–) (–) smew Mergus albellus
3 (–) (–) (–) (–) (–) (–) (–) (–) eider duck Somateria mollissima
mollissima
4 4 4 4 2 1 608.9 152.1 181 Falkland flightless
steamer duck
Tachyeres brachypterus
2 2 2 2 2 1 512 1024 22.6 ruddy shelduck Tadorna ferruginea
Casuariiformes 2 1 1 1 0 aa aa aa aa
2 1 1 1 (–) aa aa aa aa emu Dromiceius
novaehollandiae n.
Charadriiformes 13 0 0 0 0 (–) (–) (–) (–)
13 (–) (–) (–) (–) (–) (–) (–) (–) pied avocet Recurvirostra avosetta
Ciconiiformes 27 20 20 20 6 1 77.5 330.4 128
6 6 6 6 1 1 28.5 161.3 64 cattle egret Ardeola ibis
1 (–) (–) (–) (–) (–) (–) (–) (–) black stork Ciconia nigra
18 12 12 12 3 2 124.4 580.8 323 waldrapp ibis Geronticus eremita
2 2 2 2 2 1 45.3 128 45.3 marabu stork Leptoptilos
crumeniferus
Coraciiformes 4 3 4 4 2 6 80.6 322.5 181
4 3 4 4 2 6 80.6 322.5 181 kookaburra Dacelo gigas
Falconiformes 5 6 5 3 3 1 168.8 812.7 323
1 2 1 1 1 1 64 1024 512 common kestrel Falco tinnunculus
2 2 2 (–) (–) 1 90.5 (–) (–) bearded vulture Gypaetus barbatus
2 2 2 2 2 1 512 724 256 griffon vulture Gyps fulvus
Galliformes 135 119 119 113 39 0 2.09 3.27 1.21
2 2 2 2 1 0 0.92 0.96 0.38 rock partridge Alectoris graeca
2 2 1 2 (–) 0 0.7 0.74 (–) Australian
brush-turkey
Alectura lathami
lathami
15 15 15 15 5 0 1.81 2.58 1.31 brahma chicken Gallus gallus f.
domesticus
14 10 10 6 8 0 1.61 3.32 0.49 barth chicken Gallus gallus f.
domesticus
4 4 4 4 3 0 0.77 1.95 0.89 orpington chicken Gallus gallus f.
domesticus
27 22 23 22 5 0 1.54 2.82 0.9 cochin chicken Gallus gallus f.
domesticus
34 33 33 33 10 0 1.53 3.19 1.03 silky chicken Gallus gallus f.
domesticus
2 (–) (–) (–) (–) (–) (–) (–) (–) ptarmigan Lagopus muta
2 2 2 2 (–) 0 2.42 2.4 (–) Himalayan monal Lophophorus
impejanus
4 4 4 4 2 0 1.39 3.03 0.84 turkey Meleagris gallopavo
21 21 21 20 5 0 4.84 5.71 3.41 common peafowl Pavo cristatus
1 (–) (–) (–) (–) (–) (–) (–) (–) black grouse Tetrao tetrix
5 2 2 2 (–) 0 0.07 0.52 (–) capercaille Tetrao urogallus major
2 2 2 1 (–) 0 0.79 0.31 (–) satyr tragopan Tragopan satyra
Passeriformes 7 3 3 3 2 2 32 406.3 90.5
4 (–) (–) (–) (–) (–) (–) (–) (–) bearded tit Panurus biarmicus
3 3 3 3 2 2 32 406.3 90.5 alpine chough Pyrrhocorax graculus
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Galliformes were collected and analyzed by HI test. All these birds had
pre-vaccination titers # 8, with the exception of four animals: a bar-
headed goose (Anser indicus); a blue-and-yellow macaw (Ara
ararauna); a kookaburra (Dacelo gigas); and a Falkland flightless
steamer duck (Tachyeres brachypterus), with titers of 16, 16, 32, and
32, respectively. Under the conditions of this investigation, all orders
other than Galliformes showed seroconversion after the first
vaccination, reaching GMT titers between 32.0 and 658.79; and
booster vaccination led to significantly enhanced antibody production
in all these birds, with the exception of the flamingos (Phoenicopter-
iformes) and the penguins (Sphenisciformes). Generally, significant
differences in humoral immune responses between different non-
Galliformes orders were observed. Among all analyzed orders, the
Phoenicopteriformes had the highest titers, with GMTs of 658.7 at
week 5 and 696.7 at Week 10. Sphenisciformes had the lowest titers
among all non-Galliformes, with GMTs of 65.4 five weeks after
booster vaccination. Other orders with low titers, when compared
with other groups, were pelicans (Pelicaniformes), parrots (Psittaci-
formes), and owls (Strigiformes), with GMTs of 90.5, 80.6, and 65.1,
respectively, after booster vaccination. A general decrease in serum
antibody was observed in all birds, ranging from 21% in
Psittaciformes (GMT fell from 80.6 to 64) to 85% in Sphenisciformes
(GMT fell from 65.4 to 9.7). Furthermore, the penguins were the
only group returning to negative titers after the 26–week study period.
Three-hundred-ninety sera collected within 26 weeks from 135
vaccinated birds belonging to Galliformes were tested by ELISA
Order No. vacc.
No. tested GMT or S/P ratio
Species
common name
Species
scientific nameWk 0 Wk 5 Wk 10 Wk 26 Wk 0 Wk 5 Wk 10 Wk 26
Pelicaniformes 14 5 5 6 0 1 76.1 90.5 (–)
14 5 5 6 (–) 1 76.1 90.5 (–) Dalmatian pelican Pelecanus crispus
Phenicopteriformes 32 5 11 9 0 1 658.7 696.7 (–)
32 5 11 9 (–) 1 658.7 696.7 (–) greater flamingo Phoenicopterus roseus
Psittaciformes 16 16 16 16 4 1 47.5 80.6 64
2 2 2 2 2 11 64 64 45.3 blue-and-yellow
macaw
Ara ararauna
2 2 2 2 2 1 32 256 90.5 green-winged macaw Ara chloroptera
12 12 12 12 (–) 1 (–) (–) (–) patagonian conure Cyanoliseus patagonus
Sphenisciformes 40 27 29 30 10 1 64 65.4 9.7
40 27 29 30 10 1 64 65.4 9.7 Humboldt penguin Spheniscus humboldti
Strigiformes 18 11 11 11 7 1 32 128 90.5
1 (–) (–) (–) (–) (–) (–) (–) (–) Tengmalm’s owl Aegolius funereus
funereus
3 (–) (–) (–) (–) (–) (–) (–) (–) long-eared owl Asio otus
2 (–) (–) (–) (–) (–) (–) (–) (–) little owl Athene noctua
6 6 6 6 2 1 32 73.5 aai great eagle owl Bubo bubo bubo
4 4 4 4 4 1 16 161.3 64 snowy owl Nyctea scandiaca
1 (–) (–) (–) (–) (–) (–) (–) (–) European scops owl Otus scops
1 1 1 1 1 4 128 1024 256 barn owl Tyto alba
Upupiformes 1 0 0 0 0 (–) (–) (–) (–)
1 (–) (–) (–) (–) (–) (–) (–) (–) hoopoe Upupa epops
AAll vaccinated birds are listed grouped in orders and divided into species: No. vacc 5 number of vaccinated birds per species and corresponding
order; No. tested 5 number of HI or ELISA tested birds within a 26 week period; GMT or S/P ratio 5 HI or ELISA results of the corresponding
weeks and bird species; Week 05 first vaccination and sampling; Week 55 second vaccination and sampling; Week 105 third sampling; Week 26
5 fourth sampling; aa 5 autoagglutination; (–) 5 no birds tested.
Table 1. Continued.
Table 2. HI: geometric mean titres (GMT) of non-Galliformes vaccinated with an inactivated H5N2 vaccine at Weeks 0, 5, 10, and 26. CI was
calculated for orders with n $ 10. GMTs within a column with different superscripts (abc) differ significantly; GMTs within a row with different
superscripts (ABC) differ significantly.D
Orders
Blood collection
Week 0 Week 5 Week 10 Week 26
Anseriformes 1.4 (40) a A 78.4 (37) b B 266.6 (36) abc C 112.5 (30) b B
Ciconiiformes 1.2 (20) a A 77.5 (20) b B 330.4 (20) ab C 128 (6) b B
Coraciiformes 5.6 (3) a A 80.6 (4) b A 322.5 (4) abd A 181 (2) b A
Falconiformes 1 (6) a A 168.8 (5) a B 812.7 (3) ab C 322.5 (3) b ABC
Passeriformes 1.5 (3) a A 32 (3) b A 406.3 (3) ab A 90.5 (2) a A
Pelicaniformes 1 (5) a A 76.1 (5) b AB 90.5 (6) c B (–)
Phenicopteriformes 1.3 (5) a A 658.7 (11) a B 696.7 (9) ab B (–)
Psittaciformes 1.4 (16) a A 47.5 (16) b B 80.6 (16) c B 64 (4) a AB
Sphenisciformes 1 (27) a A 64 (29) b B 65.4 (30) c B 9.7 (10) a C
Strigiformes 1.2 (11) a A 32 (11) b B 128 (11) abc C 90.5 (7) a ABC
Strutioniformes aa (1) aa (1) aa (1) (–)
DOrders: All orders appertaining to non-Galliformes tested with HI test; Week 0: first vaccination and sampling; Week 5: second vaccination and
sampling; Week 10: third sampling; Week 26: fourth sampling; aa 5 autoagglutination; (n) 5 number of tested birds; (–) 5 no birds tested.
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(Table 3). The IDEXX ELISA test is validated for testing chicken
and turkey antibodies against 20 different avian influenza virus
strains. As shown in Table 1, the group of vaccinated Galliformes is
composed of 94 chickens, 6 turkeys, 21 peacocks, and 14 ‘‘others’’
(for a total of 135 birds); therefore, the validity of the results in 35 of
the tested birds may be questioned. Nevertheless, antibody titer
development of the peacock group (S/P ratio of 0.1 at Day 0; 4.8 at
Day 35; 5.7 at Day 70 [after booster vaccination]; and 3.4 at Day
182) indicated that the test also works for this Galliformes species.
For the remaining 14 birds (10.4% of the Galliformes), interpre-
tation of results is questionable.
Three birds of 119 (total sampled Galliformes at Week 0) had
positive pre-vaccination titers: one barth chicken, one brahma
chicken, and one silky chicken, with S/P ratios of 0.61, 0.52, and
1.19, respectively. After first vaccination, 80% of the Galliformes
(95 of 119 birds) showed seroconversion. Ten weeks after the first
vaccination (which was five weeks after booster vaccination), the
number of birds with S/P ratio $ 0.5 rose to 96% (108 of 113 birds
sampled at Week 10). Twenty-six weeks after first vaccination, 39
samples from Galliformes revealed an overall mean S/P ratio of 1.21
(Table 3), with 79% of the birds having titers $ 0.5. Peacocks
(Pavus cristatus) showed particularly strong response to H5N2
inoculation, reaching a mean S/P ratio of 4.84 five weeks after the
first vaccination, and of 5.71 after ten weeks. The capercailles
(Tetrao urogallus major) had the lowest titers, with an S/P ratio of
only 0.56 at Week 10. All species sampled at Week 26 showed a
decrease of antibody titers, but mean S/P ratios were still .0.5. Six
months after the first vaccination, the peacocks still had the highest
titers among all Galliformes, with an S/P ratio of 3.41.
DISCUSSION
The present study measured the humoral immune response to a
commercial adjuvanted inactivated vaccine against H5N2 avian
influenza in a multitude of bird species. Currently, there is no avian
influenza vaccine labelled and licensed for species other than
chickens. Therefore, the data presented here do not allow any
definite conclusion regarding protection in the case of an outbreak of
highly pathogenic avian influenza (HPAI).
The vaccine is safe, based on our observations. No adverse
reactions were observed following vaccination in any of the birds,
with the exception of minor swelling at the injection site in a
peacock. This observation is in agreement with the studies in
multispecies environments of Oh et al. (14) using the same vaccine;
of Philippa et al. (16,17) using an H7N1 and an H5N2 vaccine; and
of Bertelsen et al. (1) using an H5N9 vaccine. In our study, the
vaccine was applied subcutaneously or intramuscularly. The IM
inoculation route was chosen in very small birds, due to easier
handling, as an option to the subcutaneous injection; and chosen in
pelicans to avoid injection of the vaccine into their subcutaneous air-
sacs. Statistical comparison between the two administration
modalities, with regard to humoral immune response, was not
possible. The dosages were chosen on the basis of prior investigations
on the use of an H7N1 vaccine, performed by Philippa et al., which
described an inverse correlation between body weight and antibody
response in birds $1.5 kg (17).
No positive pre-vaccination titers were found with the exception of
three birds out of 119 sampled Galliformes and four birds out of 137
sampled non-Galliformes. Therefore, an exposure of a few birds to low
pathogenic avian influenza, without clinical consequences, is plausible.
Five weeks after the first vaccination, 78% of the Galliformes and
98% of the non-Galliformes birds showed seroconversion. These
two values cannot be directly compared due to the fact that two
different tests were used. At week five, the Phoenicopteriformes
(flamingos) had the highest antibody titers and showed very strong
response to first inoculation. Seroconversion rates after the second
vaccine inoculation were 96% for the Galliformes and 100% for the
non-Galliformes, leading to the conclusion that a second vaccination
within five weeks after the first vaccination generally serves its
purpose to significantly increase humoral immune response. In the
studies published by Oh et al. (14) and by Bertelsen et al. (1), a
seroconversion (HI titer $ 16) rate of 84% was denoted after
booster vaccination, which is lower than our result. By contrast,
Philippa et al. (16,17) chose a different threshold for significant
seroconversion (HI titers $ 40) and indicated a seroconversion of
80% and 81%. If we chose the same seroconversion threshold as
Philippa et al. (16,17), then 85% of our birds showed titers $40 at
Week 10. This shows that our results are comparable to those
assessed by Philippa et al. Exceptions to the positive effect of booster
Table 3. ELISA: S/P ratios of Galliformes vaccinated with an inactivated H5N2 vaccine at weeks 0, 5, 10, and 26. CI of 95% was calculated for
species with n $ 10.A S/P ratios within a column with different lowercase letters (a, b, c, d, e) differ significantly.
Species scientific nameB
Blood collection
Week 0 Week 5 Week 10 Week 26
Alectoris graeca 0.06 (2) 0.92 (2) abc 0.96 (2) abc 0.38 (1) abc
Alectura lathami lathami 0.06 (2) 0.7 (1) abce 0.74 (2) abcd (–)
Gallus gallus (barth chicken) 0.32 (10) 1.61 (10) ac 3.32 (6) d 0.49 (8) a
Gallus gallus (brahma chicken) 0.21 (15) 1.81 (15) ad 2.58 (15) cd 1.31 (5) b
Gallus gallus (cochin chicken) 0.16 (22) 1.54 (23) cd 2.82 (22) bd 0.9 (5) ab
Gallus gallus (orpington
chicken) 0.18 (4) 0.77 (4) bc 1.95 (4) abcd 0.89 (3) ab
Gallus gallus (silky chicken) 0.22 (33) 1.53 (33) ac 3.19 (33) cdf 1.03 (10) b
Lophophorus impejanus 0.05 (2) 2.42 (2) abce 2.4 (2) abcd (–)
Meleagris gallopavo 0.1 (4) 1.39 (4) ace 3.03 (4) abcd 0.84 (2) abc
Pavus cristatus 0.07 (21) 4.84 (21) e 5.71 (20) e 3.41 (5) c
Tetrao urogallus major 0.07 (2) 0.07 (2) b 0.52 (2) ab (–)
Tragopan satyra 0.12 (2) 0.79 (2) 0.31 (1) (–)
All groups 0.17 (119) 2.09 (119) 3.27 (113) 1.21 (39)
AWeek 05 first vaccination and sampling; Week 55 second vaccination and sampling; Week 105 third sampling; Week 265 fourth sampling;
n 5 number of tested birds; (–) 5 no birds tested.
BSpecies scientific name: all species appertaining to Galliformes were tested with ELISA.
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vaccination were the Sphenisciformes (penguins), Phoenicopteri-
formes (flamingos), and Pelicaniformes (pelicans). Our results for
the penguins are corroborated by the studies of Philippa et al. (17)
and Bertelsen et al. (1). In the mentioned studies, the Humboldt
penguins (Spheniscus humboldti) reached a maximum mean GMT of
76 and 48 respectively, which does not differ noticeably from our
GMT of 65.4, and leads to the conclusion that, in this species, the
deployed vaccines do not generate as high titers as in other species.
Comparing the results for Humboldt penguins in the two studies by
Philippa et al. (16,17), one can conclude that higher dosages and
different vaccine antigen can lead to significantly higher antibody
titer and a higher percentage of individuals (91%) that have GMT$
40 after booster vaccination. This clearly indicates that change of
vaccine and enhancement of the applied dosage may be adequate
solutions to species’ discrepancies. For Phoenicopteriformes, which
showed only a slight increase in humoral production induced
through booster vaccination, a single vaccination may be adequate.
This might be noteworthy, since the capture represents an important
stress to the entire flock.
Oh et al. (14) described that Pelicaniformes failed to respond to
IM vaccination with 0.5 ml/kg body weight vaccine (5.5 ml/
individual, which is elevenfold the dose administered in our study).
Our pelicans were injected with a 0.5-ml dose into the thigh muscles
and responded to vaccination with GMTs of 76.1 at Week 5 and
90.5 at Week 10. Due to their large superficial air sacs, IM injection
into the femoral region might be the preferable option, even though
their titers were significantly lower compared to some other bird
species. Oh et al. (14) did not find a titer in owls after a triple
injection of a dose of 0.5 ml/kg bodyweight. In contrast, the
Strigiformes vaccinated in our study showed reaction to vaccination
with GMT of 128 (100% $ 16) after booster vaccination,
indicating that the vaccine did induce antibody formation in this
avian order. The studies by Philippa et al. (16) and by Bertelsen et al.
(1) found GMTs of 89 (50% $ 40) and 81 (100% $ 32),
respectively, corroborating our results for the owls. The differences
in responsiveness between the various avian orders may be caused
first of all by the species and order differences, secondly by a
potentially inappropriate vaccine, thirdly by the potentially not
sufficient dosage, and fourth, by the time interval between first and
booster vaccinations.
The main aim of this study was the evaluation of humoral
immune response over a period of six months. Generally, when
GMTs of Week 10 and Week 26 were compared, a decrease of the
serum antibodies to H5 could be observed in all involved bird
species. Titer decreases were ranging between 21% (from 80.6 to 64)
and 85% (from 65.4 to 9.7), and therefore were considerable, but
these decreases did not lead to negative GMT or S/P ratios in orders
other than Sphenisciformes. The fact that, 26 weeks after first
vaccination, the GMT of Humboldt penguins’ serum was negative
(,16) raises the questions if annual revaccination is enough to
ensure protection for this species over a long period of time and if
the vaccine and the dosage used were adequate. Instead, it seems that
Psittaciformes tend to have a slower titer decrease than all other
orders. Further studies are warranted to test for other vaccines,
dosages, booster, and re-vaccination intervals.
From the 119 vaccinated Galliformes, all but the capercailles
showed a humoral reaction to first vaccination, reaching positive
titers. Within the Galliformes, the peacocks were noted for their
strong responses to first vaccination, comparable to the flamingos
within the non-Galliformes. But in contrast to them, the peacocks
increased their antibody production significantly after booster
vaccination (Table 3).
As is apparent in Table 3, it can be seen that the rock partridge
(Alectoris graeca) and the Himalayan monal (Lophoporus inpejanus),
in contrast to all other species, showed no relevant reaction to
booster vaccination. Nevertheless, it has to be noted that the number
of individuals of the two afore-mentioned species is small and
therefore, the significance of measured titers is questionable. From
Week 10–26, the species appertaining to the order of Galliformes
showed a titer decrease (from 5.71–3.42) ranging between 40% for
the peacocks and (from 3.32–0.49) 85% for the brahma chickens.
These findings show that differences in humoral responsiveness and
constancy of antibody titers have to be expected among birds
belonging to different orders, as well as among closely related birds
of the same order.
In conclusion, it could be shown that vaccination in a multispecies
collection is well tolerated and will result in significant humoral
immune response. However, no conclusions regarding protectivity of
the titers of non-Galliformes can be made at this point.
Approximately six months after the initial vaccination, titers were
decreased, leading to the conclusion that annual revaccination
appears warranted in zoo birds, as it is in chickens in high-risk areas.
In certain species such as penguins, even shorter intervals may be
necessary. However, further work on the susceptibility to AI in
species other than Galliformes and Anseriformes is needed to make
conclusive recommendations. Even so, vaccination may be a useful
strategy to save exotic and valuable birds from confinement and pre-
emptive culling in view of a potential outbreak of AI.
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